X

Health Care

3B BlackBio Dx Reports Revenue Increase Following Coris Holding Acquisition

3B BlackBio Dx Ltd (BSE: 532067), formerly known as Kilpest India Limited (KILPEST), closed at 1,612.45 on February 18, 2026,…

Lincoln Pharmaceuticals profit increases 37.7% in third quarter

Lincoln Pharmaceuticals Ltd (LINCOLN:NSE, 531633:BSE) shares closed at ₹618.60 on Wednesday, representing a 1.26% decline from the previous session's close.…

Narayana Hrudayalaya Revenue Surges 61% on United Kingdom Expansion

Narayana Hrudayalaya Limited's (NSE: NH) consolidated revenue reached record levels following the strategic acquisition of healthcare operations in the United…

IPCA Labs Posts 6.6% Revenue Growth in Q3; Profit Boosted by One-Time Asset Disposal

IPCA Laboratories Limited (NSE: IPCALAB) on Friday reported a 31.5% year-on-year increase in consolidated net profit for the third quarter…

Sanjivani Parenteral Q3 Profit Jumps 38% on Export-Led Growth

Sanjivani Parenteral Limited (BSE: 531569), a manufacturer of parenteral and oral solid dosage formulations across therapeutic areas including CNS, cardiovascular,…

Fortis Healthcare Revenue Rises 17.5% in Q3 While Exceptional Costs Weigh on Profit

Fortis Healthcare Ltd (FORTIS) shares ended lower on the National Stock Exchange and Bombay Stock Exchange on Monday, February 16,…

Earnings Summary – Akums Drugs & Pharmaceuticals Reports 14.8% Revenue Growth in Q3 FY26 Results

Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS), a pharmaceutical contract development and manufacturing organization (CDMO) announced its third-quarter and nine-month…

Eris Lifesciences Reports Record Quarterly Revenue of ₹807 Crores

Eris Lifesciences Limited (NSE: ERIS; BSE: 540596) shares closed 6.36% lower at ₹1,414.65 on Friday despite reporting record quarterly revenues…

Vijaya Diagnostic Shares Dip as Q3 FY26 Revenue Climbs 21%

Vijaya Diagnostic Centre Limited (NSE: VIJAYA) shares closed at ₹994.55, down about 1.0% intraday, on 13 February 2026 following release…

Biocon posts 9% operating revenue growth in Q3 FY26; EBITDA margin at 22%

Biocon Limited (BSE: 532523 / NSE: BIOCON) reported consolidated operating revenue growth of 9% year-on-year for the quarter ended December…